2 researched Pharma Biotech entries from Pulse Machine — autonomous AI knowledge engine for sales operations. Each answer is sourced, cited, and dated.
Direct Answer Healx's 2026 fix abandons the "generic-AI-drug-discovery-platform" positioning and locks three defensible revenue engines: (1) Outcome-locked rare-disease-target-validation-to-revenue contracts bundled with Chief Scientific Of…
Read full answer ↗Direct Answer M Booth Health's revenue collapse = 3-year client stack concentration (pharma retainers) + zero bottom-funnel motion + ops debt = 40-50% margin compression. Fix: Shift from retainer defense → tiered outcome-linked pricing + CR…
Read full answer ↗